The technology-focused lender reported solid 2025 earnings, highlighted accelerating deposit inflows and a strategic shift away from its legacy SBA portfolio. Management forecasts continued growth for 2026, banking on its digital offerings and a key securitization success.
Amid a cautiously recovering Eurozone, companies with substantial insider ownership are drawing investor attention. This alignment of interests often signals conviction in long-term growth, as seen in three standout firms from the fashion tech, aquaculture, and biotech sectors.
In a volatile market, companies with high insider ownership often signal strong alignment between management and shareholders. We examine three Asian growth firms where insiders hold over 30% of the equity.
While global small- and mid-cap stocks face headwinds, savvy investors are turning to Asia for overlooked opportunities. We examine three fundamentally strong companies with compelling growth trajectories.
While voice-AI firms like SoundHound capture headlines, data analytics giant Palantir Technologies leverages deep government ties and enterprise contracts to build a potentially more resilient growth narrative in the volatile AI sector.
All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
As Moelis & Company prepares to release its fourth-quarter earnings, analysts project stagnant year-over-year revenue. The report comes after a period of mixed performance and sector-wide volatility, setting the stage for a closely watched announcement.
As Connection (CNXN) prepares to release its quarterly results, investors are watching to see if the company can meet revenue expectations after a series of disappointments, against a backdrop of mixed performance in the tech hardware sector.
Amidst a market often swayed by speculative narratives, Zetrix AI Berhad (KLSE:ZETRIX) stands out with a track record of robust earnings growth and strong insider alignment, offering a compelling case for fundamentals-focused investors.
Industrial manufacturer IDEX (IEX) is set to release its quarterly results Wednesday morning, with Wall Street anticipating a slight revenue increase. The report comes amid a broader rally in fluid and gas handling stocks.
Aerospace and defense systems leader Woodward (NASDAQ:WWD) posted fourth-quarter results that handily exceeded Wall Street forecasts, sending its stock sharply higher. Revenue jumped 29% year-over-year to $996.5 million, while earnings per share of $2.17 beat consensus estimates by nearly 30%.
Otis Worldwide Corporation (OTIS) is showing signs of a resilient turnaround, with its core service business and booming modernization orders driving growth despite headwinds in new equipment sales, particularly in China. This analysis delves into the investment thesis gaining traction among some fund managers.
Despite a normalized growth phase, HubSpot's consistent execution, expanding profitability, and deepening product adoption among small to mid-sized businesses are building a compelling case for long-term investors, even as direct AI monetization remains on the horizon.
Work management platform Asana reports disciplined financial progress and a strategic shift towards AI-driven monetization, even as near-term seat-based revenue pressures persist in a challenging tech environment.
Despite a dominant position in analytical instruments, Waters Corporation faces headwinds from a slowing Chinese market and elevated debt. We examine the investment thesis for the life sciences tools provider, weighing its recurring revenue model against current valuation concerns.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Amidst a mixed Asian market landscape, companies with significant insider ownership are drawing investor attention. We examine three high-growth firms from South Korea and China where executives and directors have substantial skin in the game.
Universal Health Services (UHS) is drawing renewed investor interest following better-than-expected quarterly results, driven by robust behavioral health demand and a significant easing of industry-wide staffing pressures. While operational improvements bolster the near-term outlook, debates persist over valuation and the company's ability to sustain gains amid high debt levels.
NXP Semiconductors outperformed Wall Street expectations in its fourth quarter, posting $3.34 billion in revenue and providing optimistic guidance. The chipmaker highlighted improving inventory levels and strategic gains in automotive and edge AI sectors, though shares dipped post-announcement.
